HLA-C and type 1 diabetes mellitus: The major strengths of the NOD model of T1D include (1) development of spontaneous autoimmune diabetes, (2) an MHC class II molecule structurally similar to the human T1D disposing MHC class II, and (3) autoreactive T cells and autoantibodies directed at autoantigens shared between humans and mice (46, 47).